Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

KFDA Clearance for StoneChecker Software

20 Jan 2020 07:00

RNS Number : 2389A
IQ-AI Limited
20 January 2020
 

IQ-AI Ltd

("IQ-AI" or the "Company")

 

IQ-AI Announce Korean FDA Clearance to Market for StoneChecker Software, and GMP certification for Imaging Biometrics, and the appointment of Dr Balaji Ganeshan as consultant

 

IQ-AI has received notification that the Korean FDA (KFDA) has cleared StoneChecker Software for marketing in the Republic of Korea, a key market for high-tech medical imaging hardware and software. In addition, Imaging Biometrics (IB) has received GMP certification.

 

Trevor Brown, Chief Executive of IQ-AI commented, "We are delighted that StoneChecker Software has received KFDA approval for marketing in the Republic of Korea, our Korean distributor's marketing plans can now be fully implemented. It also gives me great pleasure to welcome back Dr Balaji Ganeshan to the team. Dr Ganeshan, an exceptionally innovative medical imaging entrepreneur and scientist, has invaluable expertise and ideas in a number of key technologies relevant to the Company. He will be working as a consultant for IB."

 

Dr Ganeshan, who was previously a director of StoneChecker Software, holds the position of Senior Research Associate at the Institute of Nuclear Medicine at University College London and is a prolific academic scientist in the area of medical image analysis. 

 

Dr. Balaji Ganeshan commented, "I very much look forward to working alongside Trevor Brown again, and also the team at IB, on all the technologies that IQ-AI have access to."

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

-ENDS-

 

For further information, please contact:

IQ-AI Limited

Trevor Brown/Michael Schmainda

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

About IQ-AI Ltd 

IQ-AI, Ltd, the parent company of StoneChecker® and Imaging Biometrics®, is focused on advanced and state of the art medical software and services. Imaging Biometrics develops and provides visualization and analytical solutions that enable clinicians to better diagnose and treat diseases with greater confidence. Through close collaboration with researchers and clinicians, sophisticated advancements are translated into platform-independent software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualization software seamlessly integrates into routine workflows. Please visit www.imagingbiometrics.com for further information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRSFFFAUESSEEF
Date   Source Headline
31st Jul 20097:00 amRNSHalf Yearly Report
7th May 20092:23 pmRNSDirectorate Change
27th Apr 20097:00 amRNSDirector/PDMR Shareholding
22nd Apr 200910:01 amRNSAGM & Interim Management Statement
16th Apr 20099:55 amRNSDirector/PDMR Shareholding
30th Mar 20096:29 pmRNSBlocklisting Interim Review
13th Mar 20097:00 amRNSFinal Results
18th Feb 20097:00 amRNSDirectorate Change
21st Jan 20097:00 amRNSTrading Statement
10th Dec 200810:00 amRNSDirector/PDMR Shareholding
21st Nov 20087:10 amRNSOffer Talks Terminated
21st Nov 20087:00 amRNSStatement re Possible Offer
18th Nov 20088:28 amRNSEPT Disclosure
12th Nov 200810:24 amRNSEPT Disclosure with Trade Amendment
11th Nov 20088:40 amRNSEPT Disclosure
6th Nov 20088:46 amRNSEPT Disclosure
5th Nov 20089:09 amRNSEPT Disclosure
3rd Nov 20089:12 amRNSEPT Disclosure
31st Oct 20089:47 amRNSEPT Disclosure
29th Oct 20088:45 amRNSEPT Disclosure
28th Oct 20089:38 amRNSEPT Disclosure
27th Oct 20082:14 pmRNSEPT Disclosure - Replacement
27th Oct 200810:38 amRNSEPT Disclosure
24th Oct 20089:23 amRNSEPT Disclosure
23rd Oct 20089:35 amRNSEPT Disclosure
21st Oct 20082:11 pmRNSInterim Management Statement
17th Oct 20089:24 amRNSEPT Disclosure
14th Oct 200811:36 amRNSEPT Disclosure
14th Oct 20089:31 amRNSEPT Disclosure
10th Oct 20089:44 amRNSEPT Disclosure
9th Oct 20089:26 amRNSEPT Disclosure
8th Oct 20088:53 amRNSEPT Disclosure
6th Oct 200810:48 amRNSEPT Disclosure
3rd Oct 20089:14 amBUSRule 8.3 - Flying Brands
1st Oct 20088:31 amRNSEPT Disclosure
30th Sep 20089:00 amRNSBlocklisting Interim Review
25th Sep 20088:42 amRNSEPT Disclosure
24th Sep 200810:47 amRNSEPT Disclosure
16th Sep 20088:32 amRNSEPT Disclosure
15th Sep 20089:21 amRNSEPT Disclosure
12th Sep 20089:49 amRNSEPT Disclosure - Replacement
12th Sep 20089:10 amRNSEPT Disclosure - Correction
12th Sep 20088:53 amRNSEPT Disclosure
11th Sep 20085:40 pmBUSRule 8.3 - Flying Brands
3rd Sep 20088:35 amRNSEPT Disclosure
2nd Sep 20088:54 amRNSEPT Disclosure
28th Aug 200810:07 amRNSEPT Disclosure
27th Aug 20083:17 pmBUSRule 8.3 - Flying Brands
27th Aug 20089:28 amRNSEPT Disclosure
26th Aug 200811:04 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.